OSGEP regulates islet β-cell function by modulating proinsulin translation and maintaining ER stress homeostasis in mice

Yujie Liu,Xuechun Yang,Jian Zhou,Haijun Yang,Ruimeng Yang,Peng Zhu,Rong Zhou,Tianyuan Wu,Yongchao Gao,Zhi Ye,Xi Li,Rong Liu,Wei Zhang,Honghao Zhou,Qing Li
DOI: https://doi.org/10.1038/s41467-024-54905-8
IF: 16.6
2024-12-03
Nature Communications
Abstract:Proinsulin translation and folding is crucial for glucose homeostasis. However, islet β-cell control of Proinsulin translation remains incompletely understood. Here, we identify OSGEP, an enzyme responsible for t 6 A 37 modification of tRNA NNU that tunes glucose metabolism in β-cells. Global Osgep deletion causes glucose intolerance, while β-cell-specific deletion induces hyperglycemia and glucose intolerance due to impaired insulin activity. Transcriptomics and proteomics reveal activation of the unfolded protein response (UPR) and apoptosis signaling pathways in Osgep-deficient islets, linked to an increase in misfolded Proinsulin from reduced t 6 A 37 modification. Osgep overexpression in pancreas rescues insulin secretion and mitigates diabetes in high-fat diet mice. Osgep enhances translational fidelity and alleviates UPR signaling, highlighting its potential as a therapeutic target for diabetes. Individuals carrying the C allele at rs74512655, which promotes OSGEP transcription, may show reduced susceptibility to T2DM. These findings show OSGEP is essential for islet β-cells and a potential diabetes therapy target.
multidisciplinary sciences
What problem does this paper attempt to address?